National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 64960 [E8-25959]
Download as PDF
<![CDATA[
64960
Federal Register / Vol. 73, No. 212 / Friday, October 31, 2008 / Notices
The table below provides: Types of
data collection instruments, Estimated
number of respondents, Number of
responses per respondent, Number of
total annual responses, Average burden
hour per response, and Total annual
burden hour(s).
Number of
respondents
Responses
per
respondent
Total annual
response
Burden hour
per
response*
Administrators/Supervisor Focus Group Guide .......................................
Provider Focus Group Guide ...................................................................
Behavioral Health Provider Focus Group Guide .....................................
Data Entry Focus Group Guide ...............................................................
30
30
15
15
1
1
1
1
30
30
15
15
2
2
2
2
60
60
30
30
Total ..................................................................................................
90
....................
....................
....................
180
ebenthall on PROD1PC60 with NOTICES
Data collection instrument(s)
There are no Capital Costs, Operating
Costs, and/or Maintenance Costs to
report.
Request for Comments: Your written
comments and/or suggestions are
invited on one or more of the following
points: (a) Whether the information
collection activity is necessary to carry
out an agency function; (b) whether the
agency processes the information
collected in a useful and timely fashion;
(c) the accuracy of public burden
estimate (the estimated amount of time
needed for individual respondents to
provide the requested information); (d)
whether the methodology and
assumptions used to determine the
estimates are logical; (e) ways to
enhance the quality, utility, and clarity
of the information being collected; and
(f) ways to minimize the public burden
through the use of automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology.
Direct Comments to OMB: Send your
written comments and suggestions
regarding the proposed information
collection contained in this notice,
especially regarding the estimated
public burden and associated response
time to: Office of Management and
Budget, Office of Regulatory Affairs,
New Executive Office Building, Room
10235, Washington, DC 20503,
Attention: Desk Officer for IHS.
To request more information on the
proposed collection or to obtain a copy
of the data collection instrument(s) and/
or instruction(s) contact: Ms. Janet
Ingersoll, Freedom of Information Act
Coordinator, 12300 Twinbrook Parkway,
Suite 450, Rockville, MD 20852–1601;
call non-toll free (301) 443–1116; send
via facsimile to (301) 443–2316; or send
your e-mail requests, comments, and
return address to:
Janet.Ingersoll@ihs.gov.
Comment Due Date: Comments
regarding this information collection are
best assured of having full effect if
received within 30 days of the date of
this publication.
VerDate Aug<31>2005
15:31 Oct 30, 2008
Jkt 217001
Dated: October 22, 2008.
Robert G. McSwain,
Director, Indian Health Service.
[FR Doc. E8–25795 Filed 10–30–08; 8:45 am]
BILLING CODE 4165–16–M
Annual
burden
hours
Dated: October 24, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–25959 Filed 10–30–08; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; IP HIV Vaccines.
Date: November 24, 2008.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6700B
Rockledge Drive, Bethesda, MD 20817,
(Telephone Conference Call).
Contact Person: Ellen S. Buczko, PhD.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institutes of Health/NIAID, 6700B
Rockledge Drive, MSC 7616, Bethesda, MD
20892–7616, 301–451–2676,
ebuczko1@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Cardiovascular
Ancillary Studies in Kidney Disease.
Date: November 20, 2008.
Time: 3 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Paul A. Rushing, PhD.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 747, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, (301) 594–8895,
rushingp@extra.niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
E:\FR\FM\31OCN1.SGM
31OCN1
]]>Agencies
[Federal Register Volume 73, Number 212 (Friday, October 31, 2008)]
[Notices]
[Page 64960]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-25959]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; IP HIV Vaccines.
Date: November 24, 2008.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6700B Rockledge Drive,
Bethesda, MD 20817, (Telephone Conference Call).
Contact Person: Ellen S. Buczko, PhD., Scientific Review
Officer, Scientific Review Program, Division of Extramural
Activities, National Institutes of Health/NIAID, 6700B Rockledge
Drive, MSC 7616, Bethesda, MD 20892-7616, 301-451-2676,
ebuczko1@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: October 24, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E8-25959 Filed 10-30-08; 8:45 am]
BILLING CODE 4140-01-P
